News

Paradromics Accepted to FDA Regulatory Accelerator Program and Announces New Patient Registry

Paradromics CEO Matt Angle on the Neuralink Demo

Paradromics Raises $33 Million in Funding, Achieves Breakthrough Medical Device Designation from FDA

The Neurotech Revolution goes (back) to Washington!

Paradromics CEO Matt Angle at NANS 2023

The Neurotech Revolution goes to Washington!

Paradromics Announces Neurotech Track at Built with Biology 2022

Paradromics Announces NIH Award to Fund Translational and Early-Stage Clinical Research

Paradromics Raises $20MM in Seed Funding Led by Prime Movers Lab to Advance Brain Computer Interfaces

Paradromics Develops Precision Laser Surgical Tool that can be Used to Aid BCI Implantation

Paradromics Featured on Loup Ventures’ Neurotech podcast